SITC 2024 - Scientific Programme, Venue & Exhibition
SITC 2024: Meet Assay Genie at the Society for Immunotherapy of Cancer Annual Meeting
At Assay Genie we take pride in working with some of world's leading immunologists investigate the pathways involved in activating and blocking cancer, so it will be our pleasure to meet researchers attending this year's 2024 SITC convention.
This year we have worked on and launched numerous antibodies focussed on immune checkpoints to support research in this space so we will be delighted to discuss all things cancer-related at SITC 2024.
If you get a chance to drop by we will have some Assay Genie socks to give away amongst some of our brochures discussing some new ELISA kits and antibodies we have launched.
Key information
SITC 2024 Conference Venue
Houston, Texas from the 6th to the 10th of November. With Exhibitions taking place on Friday the 8th & Saturday the 9th.
- Conference Dates: Nov. 6–10, 2024
- Exhibition Hall Dates: Nov. 8–10, 2024
- Assay Genie Booth Number: #540
SITC 2024 Meeting Programme
The SITC 2024 Annual Meeting features a wide array of expert-led sessions focused on the latest advancements in cancer immunotherapy. Keynote speakers include Dr. Carl June, who will discuss breakthroughs in CAR-T cell therapy, and Dr. Padmanee Sharma, who will cover the evolving landscape of immune checkpoint inhibitors. Dr. Miriam Merad will delve into the role of the tumor microenvironment, while Dr. Antoni Ribas will present on personalized medicine in oncology. The event is designed to foster collaboration and innovation among researchers, clinicians, and industry professionals.
For more details, you can visit the full schedule here.
Key antibodies for Immune research:
Recent Posts
-
Department of Oncology Retreat 2025
Department of Oncology RetreatAssay Genie was honoured to sponsor and participate in t …30th May 2025 -
Cure CLCN4 2025
Cure CLCN4 2025Assay Genie was honored to attend and present at the 2025 Cure CLCN4 Sc …26th May 2025 -
Alemtuzumab: Mechanism, Applications, and Biosimilar Advancements
Quick Facts About AlemtuzumabWhat is Alemtuzumab?Alemtuzumab is a monoclonal antibody …26th May 2025